Jiangxi Boye Pharmaceutical Technology Co., Ltd. is a high-tech enterprise specializing in the research, development, and industrialization of specialty active pharmaceutical ingredients (APIs), key pharmaceutical intermediates, and related materials. The company is committed to establishing a leading pharmaceutical and chemical service platform in China, making pharmaceutical and chemical R&D more efficient and environmentally friendly. Over the years, it has consistently served the pharmaceutical sector, accumulating advanced R&D technical capabilities and continuously providing services to well-known domestic and international pharmaceutical companies and research institutions.

The company's main products include: (1) Specialty APIs and pharmaceutical intermediates, such as Plerixafor and its key intermediates; (2) Pesticide intermediates and liquid crystal material intermediates, including thiadiazole and triphenylphosphine, which have been sold worldwide and highly praised by customers; (3) Key impurities of APIs, including Esomeprazole impurities, Mesalazine impurities, Memantine hydrochloride impurities, Paclitaxel impurities, etc.; (4) Other chemical intermediates and operations in hazardous chemicals.

Adhering to the advanced cultural philosophy of "Quality First, Integrity as the Foundation, Customer Service, and Technological Innovation," Boye Pharmaceutical strictly follows international standard quality management systems, maintains standardized product supply management, and continuously improves its service system, dedicated to providing high-quality products and services for global drug research, development, and production.